152 related articles for article (PubMed ID: 32724411)
1. Expression, association with clinicopathological features and prognostic potential of CEP55, p-Akt, FoxM1 and MMP-2 in astrocytoma.
Nie S; Lou L; Wang J; Cui J; Wu W; Zhang Q; Liu Y; Su L; Chang Y; Guo W; Shen H; Xing L; Li Y
Oncol Lett; 2020 Aug; 20(2):1685-1694. PubMed ID: 32724411
[TBL] [Abstract][Full Text] [Related]
2. α-catenin interaction with YAP/FoxM1/TEAD-induced CEP55 supports liver cancer cell migration.
Tang Y; Thiess L; Weiler SME; Tóth M; Rose F; Merker S; Ruppert T; Schirmacher P; Breuhahn K
Cell Commun Signal; 2023 Jun; 21(1):162. PubMed ID: 37381005
[TBL] [Abstract][Full Text] [Related]
3. Downstream targets of FOXM1: CEP55 and HELLS are cancer progression markers of head and neck squamous cell carcinoma.
Waseem A; Ali M; Odell EW; Fortune F; Teh MT
Oral Oncol; 2010 Jul; 46(7):536-42. PubMed ID: 20400365
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of centrosomal protein 55 is associated with unfavorable prognosis and tumor invasion in epithelial ovarian carcinoma.
Zhang W; Niu C; He W; Hou T; Sun X; Xu L; Zhang Y
Tumour Biol; 2016 May; 37(5):6239-54. PubMed ID: 26615423
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of Forkhead box M1 protein associates with aggressive tumor features and poor prognosis of hepatocellular carcinoma.
Sun HC; Li M; Lu JL; Yan DW; Zhou CZ; Fan JW; Qin XB; Tang HM; Peng ZH
Oncol Rep; 2011 Jun; 25(6):1533-9. PubMed ID: 21431285
[TBL] [Abstract][Full Text] [Related]
6. [Correlation between expression of forkhead box M1 (FOXM1) and clinicopathological features and prognosis in patients with non-small cell lung cancer (NSCLC)].
Liu YQ; Guo RH; Liu LK; Gao W; Zhu CJ; Wei J; Shu YQ
Zhonghua Zhong Liu Za Zhi; 2011 Jun; 33(6):426-30. PubMed ID: 21875482
[TBL] [Abstract][Full Text] [Related]
7. Increased expression of Forkhead box M1 transcription factor is associated with clinicopathological features and confers a poor prognosis in human hepatocellular carcinoma.
Egawa M; Yoshida Y; Ogura S; Kurahashi T; Kizu T; Furuta K; Kamada Y; Chatani N; Hamano M; Kiso S; Hikita H; Tatsumi T; Eguchi H; Nagano H; Doki Y; Mori M; Takehara T
Hepatol Res; 2017 Oct; 47(11):1196-1205. PubMed ID: 28002884
[TBL] [Abstract][Full Text] [Related]
8. The function and molecular mechanism of CEP55 in anaplastic thyroid cancer.
Li YH; Xu KC; Huang GM; Zang HL
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9549-9555. PubMed ID: 33015797
[TBL] [Abstract][Full Text] [Related]
9. USP22 promotes the G1/S phase transition by upregulating FoxM1 expression via β-catenin nuclear localization and is associated with poor prognosis in stage II pancreatic ductal adenocarcinoma.
Ning Z; Wang A; Liang J; Xie Y; Liu J; Feng L; Yan Q; Wang Z
Int J Oncol; 2014 Oct; 45(4):1594-608. PubMed ID: 24993031
[TBL] [Abstract][Full Text] [Related]
10. High levels of centrosomal protein 55 expression is associated with poor clinical prognosis in patients with cervical cancer.
Qi J; Liu G; Wang F
Oncol Lett; 2018 Jun; 15(6):9347-9352. PubMed ID: 29805659
[TBL] [Abstract][Full Text] [Related]
11. FOXM1 promotes tumor cell invasion and correlates with poor prognosis in early-stage cervical cancer.
He SY; Shen HW; Xu L; Zhao XH; Yuan L; Niu G; You ZS; Yao SZ
Gynecol Oncol; 2012 Dec; 127(3):601-10. PubMed ID: 22943878
[TBL] [Abstract][Full Text] [Related]
12. Linking expression of FOXM1, CEP55 and HELLS to tumorigenesis in oropharyngeal squamous cell carcinoma.
Janus JR; Laborde RR; Greenberg AJ; Wang VW; Wei W; Trier A; Olsen SM; Moore EJ; Olsen KD; Smith DI
Laryngoscope; 2011 Dec; 121(12):2598-603. PubMed ID: 22109759
[TBL] [Abstract][Full Text] [Related]
13. Aberrant FoxM1B expression increases matrix metalloproteinase-2 transcription and enhances the invasion of glioma cells.
Dai B; Kang SH; Gong W; Liu M; Aldape KD; Sawaya R; Huang S
Oncogene; 2007 Sep; 26(42):6212-9. PubMed ID: 17404569
[TBL] [Abstract][Full Text] [Related]
14. CEP55 promotes cell proliferation and inhibits apoptosis via the PI3K/Akt/p21 signaling pathway in human glioma U251 cells.
Li F; Jin D; Tang C; Gao D
Oncol Lett; 2018 Apr; 15(4):4789-4796. PubMed ID: 29552118
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of forkhead box M1 is associated with aggressive phenotype and poor prognosis in estrogen receptor-positive breast cancer.
Ahn H; Sim J; Abdul R; Chung MS; Paik SS; Oh YH; Park CK; Jang K
J Korean Med Sci; 2015 Apr; 30(4):390-7. PubMed ID: 25829806
[TBL] [Abstract][Full Text] [Related]
16. CEP55 promotes epithelial-mesenchymal transition in renal cell carcinoma through PI3K/AKT/mTOR pathway.
Chen H; Zhu D; Zheng Z; Cai Y; Chen Z; Xie W
Clin Transl Oncol; 2019 Jul; 21(7):939-949. PubMed ID: 30607788
[TBL] [Abstract][Full Text] [Related]
17. Forkhead box protein M1 predicts outcome in human osteosarcoma.
Fan CL; Jiang J; Liu HC; Yang D
Int J Clin Exp Med; 2015; 8(9):15563-8. PubMed ID: 26629049
[TBL] [Abstract][Full Text] [Related]
18. Circ-8073 regulates CEP55 by sponging miR-449a to promote caprine endometrial epithelial cells proliferation via the PI3K/AKT/mTOR pathway.
Liu X; Zhang L; Liu Y; Cui J; Che S; An X; Song Y; Cao B
Biochim Biophys Acta Mol Cell Res; 2018 Aug; 1865(8):1130-1147. PubMed ID: 29800603
[TBL] [Abstract][Full Text] [Related]
19. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.
Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A
J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906
[TBL] [Abstract][Full Text] [Related]
20. [Clinical significance of FOXM1 and Gli-1 protein expression in high-grade ovarian serous carcinoma].
Zhang J; Li ZY; Duan XJ; Fan XM; Liu WN; Li YH
Zhonghua Zhong Liu Za Zhi; 2016 Dec; 38(12):904-908. PubMed ID: 27998466
[No Abstract] [Full Text] [Related]
[Next] [New Search]
